PURA Coronavirus Market Update #1 - CBD Beverage Sales, Annual Report, M&A
March 30 2020 - 12:18PM
InvestorsHub NewsWire
PURA Coronavirus Market Update #1 –
CBD Beverage Sales, Annual Report, M&A
Dallas, TX -- March 30, 2020 --
InvestorsHub NewsWire -- Puration, Inc. (USOTC:
PURA) today released a Coronavirus market update. In
light of the overall stock market volatility and general economic
concerns, PURA plans to post periodic updates to specifically
address any impacts to the company’s operations or
outlook.
Coronavirus Market
Conditions Potentially Enhance
Sales
Today PURA’s revenue is primarily
generated by the sales of its EVERx CBD Sports Water. At this
time, PURA has not experienced any event that would indicate a
negative impact to sales. On the contrary, EVERx CBD Sports
Water is a best seller right now on the North American Cannabis
Holdings, Inc. (USOTC:
USMJ) www.USMJ.com
eCommerce site. Multiple
reports are out right now indicating that cannabis sales are up in
the midst of the increasing Corona Crisis isolation being
experienced by much of the U.S.
population.
Product Inventory
Restocked Just Prior To
Lockdown
Fortunately, and by sheer luck, PURA
executed a production run of EVERx CBD Sports Water just prior to
the lockdown. So, for the immediate future, PURA’s supply of
EVERx CBD Sports Water is sufficient to support ongoing
sales.
Upcoming Financial
Reports Not Impacted By
Coronavirus
PURA’s annual financial report will soon
be published and obviously the Coronavirus market does not have any
impact on last year’s financial performance. PURA
historically files for a reporting extension and will likely file
for an extension on the upcoming financial report. The first
quarter financial report will be coming soon after the annual
report and at this time the Coronavirus market conditions are not
anticipated to have a negative impact on the first
quarter.
Stock Market
Volatility
Wow, right? There is an abundance of
reporting with an endless variety of explanations, forecasts and
recommendations regarding the prevailing stock market. What
could we possibly add to stand out? Fear, uncertainty and
doubt seems to rule the market right now. PURA at about $0.01
today has a 52-week high of over $0.09 and was over $0.04 in
February just before the Coronavirus impacted the
stockmarket. Our objective in this update and future
Coronavirus market updates will be to simply provide the latest
most up-to-date insight into the company’s current situation and
outlook regarding how the prevailing market conditions might be
having an impact. We will try in these updates to at least
mitigate uncertainty and doubt. You will have to manage fear
on your own and make your own decisions regarding the PURA share
price as a reflection of the company’s value in general and in
light of the Coronavirus market.
CBD M&A
Campaign Continues
PURA announced the launch of a campaign to
acquire other CBD beverage, edible and topical operations and in
fact executed its first two acquisitions. At this time there
is no change to the company’s campaign. Management speculates
that the Coronavirus market may even improve the market for
potential acquisitions.
Management plans to publish updates on the
company website weekly and more frequently if
warranted.
For more information on Puration,
visit http://www.purationinc.com
Disclaimer/Safe
Harbor:
This news release contains forward-looking
statements within the meaning of the Securities Litigation Reform
Act. The statements reflect the Company's current views with
respect to future events that involve risks and uncertainties.
Among others, these risks include the expectation that any of the
companies mentioned herein will achieve significant sales, the
failure to meet schedule or performance requirements of the
companies' contracts, the companies' liquidity position, the
companies' ability to obtain new contracts, the emergence of
competitors with greater financial resources and the impact of
competitive pricing. In the light of these uncertainties, the
forward-looking events referred to in this release might not occur.
These statements have not been evaluated by the Food and Drug
Administration. These products are not intended to diagnose, treat,
cure, or prevent any disease.
Contact:
Puration, Inc.
Brian Shibley,
info@aciconglomerated.com
Puration (CE) (USOTC:PURA)
Historical Stock Chart
From Aug 2024 to Sep 2024
Puration (CE) (USOTC:PURA)
Historical Stock Chart
From Sep 2023 to Sep 2024